CYTK vs XPEV · rev $28.6M vs rev $895.7M
Cytokinetics Inc (CYTK) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
CYTK currently screens at market cap $4.05B. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the CYTK and XPEV stock pages for the full models.
Not investment advice.